ATE533747T1 - Verfahren zur herstellung von tetrahydrochinolinderivaten - Google Patents
Verfahren zur herstellung von tetrahydrochinolinderivatenInfo
- Publication number
- ATE533747T1 ATE533747T1 AT07741046T AT07741046T ATE533747T1 AT E533747 T1 ATE533747 T1 AT E533747T1 AT 07741046 T AT07741046 T AT 07741046T AT 07741046 T AT07741046 T AT 07741046T AT E533747 T1 ATE533747 T1 AT E533747T1
- Authority
- AT
- Austria
- Prior art keywords
- tetrahydrocinoline
- derivatives
- producing
- tetrahydrocinoline derivatives
- producing tetrahydrocinoline
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006092783 | 2006-03-30 | ||
| JP2006322845 | 2006-11-30 | ||
| PCT/JP2007/057610 WO2007116922A1 (en) | 2006-03-30 | 2007-03-29 | A process for preparing tetrahydroquinoline derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE533747T1 true ATE533747T1 (de) | 2011-12-15 |
Family
ID=38123770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07741046T ATE533747T1 (de) | 2006-03-30 | 2007-03-29 | Verfahren zur herstellung von tetrahydrochinolinderivaten |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8084611B2 (de) |
| EP (2) | EP2007728B1 (de) |
| JP (1) | JP5275971B2 (de) |
| AR (1) | AR060174A1 (de) |
| AT (1) | ATE533747T1 (de) |
| ES (1) | ES2374315T3 (de) |
| PE (1) | PE20071150A1 (de) |
| TW (1) | TW200808731A (de) |
| UY (1) | UY30244A1 (de) |
| WO (1) | WO2007116922A1 (de) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2207775T3 (pl) * | 2007-11-05 | 2012-08-31 | Novartis Ag | Pochodne 4-benzyloamino-1-karboksyacylo-piperydyny jako inhibitory CETP użyteczne do leczenia chorób, takich jak hiperlipidemia lub stwardnienie tętnic |
| AU2008333272B2 (en) * | 2007-12-03 | 2012-03-29 | Novartis Ag | 1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis |
| CN102020608B (zh) * | 2010-09-17 | 2012-09-05 | 清华大学 | 喹啉化合物的制备方法 |
| CN107108558B (zh) * | 2014-08-12 | 2019-11-19 | 狄智玛制药私人有限公司 | 制备用于制备四氢喹啉衍生物的合成中间体的方法 |
| WO2017023165A1 (en) * | 2015-08-04 | 2017-02-09 | Dezima Pharma B.V. | Pharmaceutical composition and therapeutic combination comprising a cholesteryl ester transfer protein inhibitor and an atp citrate lyase inhibitor – ampk activator |
| US10085999B1 (en) | 2017-05-10 | 2018-10-02 | Arixa Pharmaceuticals, Inc. | Beta-lactamase inhibitors and uses thereof |
| MX2020004071A (es) | 2017-10-02 | 2020-07-28 | Arixa Pharmaceuticals Inc | Derivados de aztreonam y usos de los mismos. |
| EP3590927A1 (de) | 2018-07-05 | 2020-01-08 | Bayer Animal Health GmbH | Neuartige verbindungen zur bekämpfung von arthropoden |
| ES2991492T3 (es) | 2018-10-01 | 2024-12-03 | Arixa Pharmaceuticals Inc | Derivados de relebactam y usos de los mismos |
| US11008321B2 (en) | 2019-03-12 | 2021-05-18 | Arixa Pharmaceuticals, Inc. | Crystalline form of an avibactam derivative |
| WO2020219258A1 (en) | 2019-04-25 | 2020-10-29 | Arixa Pharmaceuticals, Inc. | Methods of synthesizing aztreonam derivatives |
| TWI843678B (zh) * | 2019-06-18 | 2024-05-21 | 美商美國禮來大藥廠 | 用於製備2-(2,6-二氯苯基)-1-[(1s,3r)-3-(羥甲基)-5-(3-羥基-3-甲基丁基)-1-甲基-3,4-二氫異喹啉-2(1h)-基]乙烯酮之方法及中間物 |
| CN117098541A (zh) | 2020-11-25 | 2023-11-21 | 阿卡格拉医药公司 | 用于递送核酸的脂质纳米粒及相关使用方法 |
| ES2988112T3 (es) | 2021-03-05 | 2024-11-19 | Newamsterdam Pharma B V | Obicetrapib para el tratamiento de demencias |
| IL310115A (en) | 2021-07-26 | 2024-03-01 | Newamsterdam Pharma B V | Treatment of his hyporesponders |
| CA3242880A1 (en) | 2021-12-30 | 2023-07-06 | Newamsterdam Pharma B.V. | COMBINATION OF OBITECRAPIB AND SGLT2 INHIBITOR |
| CN114516865B (zh) * | 2022-03-09 | 2023-06-23 | 成都师范学院 | 一类D-π-A型有机共轭分子及其制备方法和应用 |
| WO2023230587A2 (en) | 2022-05-25 | 2023-11-30 | Akagera Medicines, Inc. | Lipid nanoparticles for delivery of nucleic acids and methods of use thereof |
| US12006305B2 (en) | 2022-07-05 | 2024-06-11 | Newamsterdam Pharma B.V. | Salts of obicetrapib and processes for their manufacture and intermediates thereof |
| WO2024042061A1 (en) | 2022-08-22 | 2024-02-29 | Newamsterdam Pharma B.V. | Obicetrapib and ezetimibe combination treatment and fixed dose pharmaceutical compositions |
| EP4661865A1 (de) | 2023-02-07 | 2025-12-17 | NewAmsterdam Pharma B.V. | Obicetrapib- und ezetimibkombinationsbehandlung und pharmazeutische zusammensetzungen mit fixer dosis |
| WO2025059594A1 (en) | 2023-09-15 | 2025-03-20 | Newamsterdam Pharma B.V. | METHODS FOR TREATING HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HeFH) |
| WO2025093436A1 (en) | 2023-11-01 | 2025-05-08 | Newamsterdam Pharma B.V. | Treatment and prevention of age-related macular degeneration using a cetp inhibitor |
| WO2025093129A1 (en) | 2023-11-01 | 2025-05-08 | Newamsterdam Pharma B.V. | Treatment and prevention of age-related macular degeneration using a cetp inhibitor |
| WO2025146262A1 (en) | 2024-01-03 | 2025-07-10 | Newamsterdam Pharma B.V. | Obicetrapib for use in the treatment of hemoglobinopathies |
| WO2025146415A1 (en) | 2024-01-03 | 2025-07-10 | Newamsterdam Pharma B.V. | Improvement in atherosclerotic plaque characteristics with obicetrapib |
| EP4746866A1 (de) | 2024-09-17 | 2026-05-27 | NewAmsterdam Pharma B.V. | Obicetrapib zur verwendung in verfahren zur behandlung einer person mit heterozygoter familiärer hypercholesterolämie (hefh) und/oder atherosklerotischer kardiovaskulärer erkrankung (ascvd) |
| WO2026062049A1 (en) | 2024-09-21 | 2026-03-26 | Newamsterdam Pharma B.V., | Obicetrapib for the treatment of dementias |
| WO2026063944A1 (en) | 2024-09-21 | 2026-03-26 | Newamsterdam Pharma B.V. | Obicetrapib for the treatment of dementias |
| WO2026087915A1 (en) | 2024-10-25 | 2026-04-30 | Newamsterdam Pharma B.V. | Treatment and prevention of sepsis or other dysregulated inflammatory responses using cetp inhibitor obicetrapib |
| WO2026115019A1 (en) | 2024-11-27 | 2026-06-04 | Newamsterdam Pharma B.V. | Enantioselective process for preparing tetrahydroquinoline derivatives |
| WO2026146129A1 (en) | 2025-01-02 | 2026-07-09 | Newamsterdam Pharma B.V. | Magnesium salts of obicetrapib |
| WO2026146132A1 (en) | 2025-01-02 | 2026-07-09 | Newamsterdam Pharma B.V. | Salts of obicetrapib |
| WO2026146133A1 (en) | 2025-01-02 | 2026-07-09 | Newamsterdam Pharma B.V. | Deuterated derivatives of obicetrapib |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI82094C (fi) | 1989-02-16 | 1997-09-09 | Valmet Corp | Anvaendning av en legering av ett metallpulver och en karbid eller nitrid innefattande belaeggningskomposition foer en i en pappersmaskin anvaendbar yankeecylinder |
| IL93610A0 (en) | 1989-03-08 | 1990-12-23 | Merck Sharp & Dohme | Tetrahydroquinoline derivatives,their preparation and pharmaceutical compositions containing them |
| ATE117294T1 (de) | 1989-08-11 | 1995-02-15 | Ici Plc | Chinolin-derivate, verfahren zu ihrer herstellung und ihre anwendung als arzneimittel. |
| JPH03161360A (ja) | 1989-11-21 | 1991-07-11 | Tdk Corp | サーマルヘッド |
| JPH03216566A (ja) | 1990-01-22 | 1991-09-24 | Mitsubishi Electric Corp | Ｃｃｄリニアイメージセンサのテスト装置 |
| GB9010394D0 (en) | 1990-05-09 | 1990-06-27 | Ici Plc | Heterocyclic compounds |
| IE914573A1 (en) | 1991-01-17 | 1992-07-29 | Ici Plc | Boron compounds |
| JPH05213884A (ja) | 1991-06-14 | 1993-08-24 | Upjohn Co:The | 新規な４−アミノキノリン類およびこれを有効成分とする高血圧・鬱血性心不全の予防・治療剤 |
| US5576460A (en) | 1994-07-27 | 1996-11-19 | Massachusetts Institute Of Technology | Preparation of arylamines |
| US5929281A (en) | 1996-04-19 | 1999-07-27 | Tosoh Corporation | Process for producing heterocyclic aromatic amine or arylamine |
| US6197786B1 (en) * | 1998-09-17 | 2001-03-06 | Pfizer Inc | 4-Carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines |
| US6147090A (en) | 1998-09-17 | 2000-11-14 | Pfizer Inc. | 4-carboxyamino-2-methyl-1,2,3,4,-tetrahydroquinolines |
| GT199900147A (es) | 1998-09-17 | 1999-09-06 | 1, 2, 3, 4- tetrahidroquinolinas 2-sustituidas 4-amino sustituidas. | |
| HN2000000203A (es) | 1999-11-30 | 2001-06-13 | Pfizer Prod Inc | Procedimiento para la obtencion de 1,2,3,4-tetrahidroquinolinas 4-carboxiamino-2- sustituidas. |
| EP1167521A1 (de) | 2000-06-30 | 2002-01-02 | Aventis Animal Nutrition S.A. | Beschichtete enzymenthaltende Katalysator |
| AU2001279274A1 (en) | 2000-07-25 | 2002-02-05 | Digeo, Inc. | Allowance account for interactive television system |
| JP2002053557A (ja) * | 2000-08-14 | 2002-02-19 | Japan Tobacco Inc | アポリポ蛋白ａ−ｉ産生促進薬 |
| CA2420040C (en) * | 2000-08-18 | 2009-02-03 | Ajinomoto Co., Inc. | New phenylalanine derivatives |
| SE0101161D0 (sv) * | 2001-03-30 | 2001-03-30 | Astrazeneca Ab | New compounds |
| CA2445623A1 (en) | 2001-04-30 | 2002-11-07 | Pfizer Products Inc. | Methods for preparing cetp inhibitors |
| EP1318139A3 (de) | 2001-12-07 | 2003-07-30 | Solvias AG | Verfahren zur Herstellung von 3-Aminokarbonsäuren und deren Estern |
| US6903233B2 (en) | 2002-03-11 | 2005-06-07 | Takasago International Corporation | Process for producing optically active 3-halogenocarboxylic acid ester and 3-azidocarboxylic acid ester |
| US7332514B2 (en) | 2002-08-30 | 2008-02-19 | Japan Tobacco Inc. | Dibenzylamine compound and medicinal use thereof |
| PL376156A1 (en) | 2002-10-04 | 2005-12-27 | Millennium Pharmaceuticals, Inc. | Pgd2 receptor antagonists for the treatment of inflammatory diseases |
| JP2004238322A (ja) | 2003-02-05 | 2004-08-26 | Sumika Fine Chemicals Co Ltd | （ｒ）−３−アミノペンタンニトリルメタンスルホン酸塩の製造方法 |
| WO2004072041A1 (en) | 2003-02-12 | 2004-08-26 | Care X S.A. | Tetrahydroquinolines as agonists of liver- x receptors |
| EP1594843B1 (de) | 2003-02-18 | 2013-05-22 | Takasago International Corporation | VERFAHREN ZUR HERSTELLUNG eines OPTISCH AKTIVEM beta-Aminosäurederivates |
| JP2006521344A (ja) | 2003-03-28 | 2006-09-21 | ファイザー・プロダクツ・インク | アテローム性動脈硬化症および肥満の治療のためのｃｅｔｐ阻害剤としての１，２，４−置換１，２，３，４−テトラヒドロ−および１，２−ジヒドロ−キノリンおよび１，２，３，４−テトラヒドロ−キノキサリン誘導体 |
| US7145030B2 (en) | 2003-04-24 | 2006-12-05 | Ajinomoto Co., Inc. | Production method for optically active N-aryl-β-amino acid compounds |
| JP2004339205A (ja) | 2003-04-24 | 2004-12-02 | Ajinomoto Co Inc | 光学活性Ｎ−アリール−β−アミノ酸化合物の製造方法 |
| DE602004025132D1 (de) | 2003-09-18 | 2010-03-04 | Takasago Perfumery Co Ltd | Asymmetrische reduktive aminierung von ketosäurederivaten zur herstellung von aminosäurederivaten |
| EP1734961A2 (de) * | 2004-03-09 | 2006-12-27 | Elan Pharmaceuticals, Inc. | Verfahren zur behandlung von amyloidose mit bicyclischen aspartyl-proteasehemmern |
| BRPI0508966A (pt) | 2004-03-26 | 2007-08-21 | Lilly Co Eli | composto, composição farmacêutica, e, uso de um composto |
| UA90269C2 (ru) | 2004-04-02 | 2010-04-26 | Мицубиси Танабе Фарма Корпорейшн | Тетрагидрохинолиновые производные и способ их получения |
| JP2005336083A (ja) | 2004-05-26 | 2005-12-08 | Sumitomo Chemical Co Ltd | 芳香族アミノ化合物の製造方法 |
| US20080269284A1 (en) | 2004-06-24 | 2008-10-30 | Eli Lilly And Company | Compounds and Methods for Treating Dyslipidemia |
-
2007
- 2007-03-26 UY UY30244A patent/UY30244A1/es not_active Application Discontinuation
- 2007-03-26 TW TW096110313A patent/TW200808731A/zh unknown
- 2007-03-28 AR ARP070101288A patent/AR060174A1/es not_active Application Discontinuation
- 2007-03-29 WO PCT/JP2007/057610 patent/WO2007116922A1/en not_active Ceased
- 2007-03-29 US US12/295,618 patent/US8084611B2/en active Active
- 2007-03-29 JP JP2009502420A patent/JP5275971B2/ja active Active
- 2007-03-29 AT AT07741046T patent/ATE533747T1/de active
- 2007-03-29 ES ES07741046T patent/ES2374315T3/es active Active
- 2007-03-29 EP EP07741046A patent/EP2007728B1/de active Active
- 2007-03-29 EP EP09174862A patent/EP2154132A1/de not_active Withdrawn
- 2007-03-29 PE PE2007000358A patent/PE20071150A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP5275971B2 (ja) | 2013-08-28 |
| UY30244A1 (es) | 2007-11-30 |
| ES2374315T3 (es) | 2012-02-15 |
| US20090292125A1 (en) | 2009-11-26 |
| EP2007728A1 (de) | 2008-12-31 |
| PE20071150A1 (es) | 2007-12-03 |
| US8084611B2 (en) | 2011-12-27 |
| TW200808731A (en) | 2008-02-16 |
| EP2007728B1 (de) | 2011-11-16 |
| EP2154132A1 (de) | 2010-02-17 |
| AR060174A1 (es) | 2008-05-28 |
| JP2009532345A (ja) | 2009-09-10 |
| WO2007116922A1 (en) | 2007-10-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE455105T1 (de) | Verfahren zur herstellung von difluormethylpyrazolylcarboxylaten | |
| EP2170785A4 (de) | Verfahren zur herstellung von hydrofluorolefinen | |
| ATE408604T1 (de) | Verfahren zur herstellung von 1-alkyl-3- phenyluracilen | |
| ATE480531T1 (de) | Verfahren zur herstellung von benzopyran-2- olderivaten | |
| ATE535568T1 (de) | Verfahren zur herstellung von polyethylenzusammensetzungen | |
| ATE516816T1 (de) | Verfahren zur herstellung von impfstoffen | |
| ATE529527T1 (de) | Verfahren zur herstellung von alkoholen | |
| ATE408609T1 (de) | Verfahren zur herstellung von n-phenylpyrazol-1- carboxamiden | |
| ATE430480T1 (de) | Verfahren zur herstellung von nährmittelzusammensetzungen | |
| ATE516362T1 (de) | Verfahren zur herstellung von biodiesel | |
| DE602007001585D1 (de) | Verfahren zur herstellung von kunstlatex | |
| ATE546436T1 (de) | Verfahren zur herstellung von 2-amino-5- cyanobenzoesäurederivaten | |
| DE602006015090D1 (de) | Verfahren zur herstellung von gezielt durchlässigen laminaten | |
| ATE518847T1 (de) | Verfahren zur herstellung von betamimetika | |
| ATE548345T1 (de) | Verfahren zur herstellung von agomelatin | |
| ATE523483T1 (de) | Verfahren zur herstellung von betainen | |
| ATE489015T1 (de) | Verfahren zur herstellung von verschlüssen | |
| DE602008006766D1 (de) | Verfahren zur herstellung von würzwürfeln | |
| ATE540585T1 (de) | Verfahren zur herstellung von tomatenpaste | |
| ATE554088T1 (de) | Verfahren zur herstellung von pyridoä2,1- aüisochinolinderivaten | |
| DE502006001281D1 (de) | Verfahren zur herstellung substituierter biphenyle | |
| ATE399157T1 (de) | Verfahren zur herstellung von telmisartan | |
| EP2135979A4 (de) | Verfahren zur herstellung von nitrid-einkristall | |
| DE602007000239D1 (de) | Verfahren zur Herstellung von hohlen Artikeln | |
| ATE431868T1 (de) | Verfahren zur herstellung laufmaschenfester textilien |